Intuitive Surgical, Inc. $ISRG is Headlands Technologies LLC’s 10th Largest Position

Headlands Technologies LLC decreased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 34.4% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 18,962 shares of the medical equipment provider’s stock after selling 9,961 shares during the period. Intuitive Surgical comprises approximately 1.2% of Headlands Technologies LLC’s portfolio, making the stock its 10th biggest holding. Headlands Technologies LLC’s holdings in Intuitive Surgical were worth $10,304,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Aaron Wealth Advisors LLC grew its stake in shares of Intuitive Surgical by 0.8% during the 2nd quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock worth $1,374,000 after acquiring an additional 19 shares during the period. Evergreen Capital Management LLC lifted its holdings in Intuitive Surgical by 0.5% during the first quarter. Evergreen Capital Management LLC now owns 4,288 shares of the medical equipment provider’s stock valued at $2,124,000 after purchasing an additional 20 shares during the last quarter. Rise Advisors LLC lifted its holdings in Intuitive Surgical by 5.6% during the first quarter. Rise Advisors LLC now owns 378 shares of the medical equipment provider’s stock valued at $187,000 after purchasing an additional 20 shares during the last quarter. Pinnacle Bancorp Inc. boosted its position in Intuitive Surgical by 4.1% during the second quarter. Pinnacle Bancorp Inc. now owns 532 shares of the medical equipment provider’s stock worth $289,000 after purchasing an additional 21 shares during the period. Finally, Vertex Planning Partners LLC increased its stake in shares of Intuitive Surgical by 2.3% in the second quarter. Vertex Planning Partners LLC now owns 917 shares of the medical equipment provider’s stock worth $498,000 after purchasing an additional 21 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 104 shares of the business’s stock in a transaction that occurred on Wednesday, December 10th. The shares were sold at an average price of $559.90, for a total value of $58,229.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Henry L. Charlton sold 13,731 shares of the stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total transaction of $7,963,980.00. Following the completion of the transaction, the executive vice president directly owned 3,056 shares in the company, valued at $1,772,480. The trade was a 81.80% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 109,043 shares of company stock valued at $60,816,225 over the last quarter. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Down 0.9%

Intuitive Surgical stock opened at $542.32 on Friday. The stock has a market cap of $194.41 billion, a price-to-earnings ratio of 71.74, a PEG ratio of 4.98 and a beta of 1.68. The business has a 50-day simple moving average of $529.62 and a 200 day simple moving average of $505.69. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, beating the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The firm had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.41 billion. During the same quarter last year, the firm posted $1.84 EPS. The company’s revenue was up 22.9% compared to the same quarter last year. On average, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on ISRG. Zacks Research upgraded shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research note on Friday, October 24th. Deutsche Bank Aktiengesellschaft restated a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Piper Sandler lifted their price target on Intuitive Surgical from $595.00 to $610.00 and gave the company an “overweight” rating in a research report on Wednesday, October 22nd. Raymond James Financial set a $603.00 price objective on Intuitive Surgical and gave the company an “outperform” rating in a research note on Wednesday, October 22nd. Finally, BTIG Research raised their target price on Intuitive Surgical from $529.00 to $589.00 and gave the stock a “buy” rating in a research note on Wednesday, October 22nd. Two analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $608.79.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.